Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-23
2009-06-23
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S357000, C546S329000, C548S335100, C548S341100
Reexamination Certificate
active
07550497
ABSTRACT:
New phosphoramide derivatives of formula (I) and the salts and solvates thereof, wherein the meanings of the various substituents are as disclosed in the description. Said compounds are useful as antiinflammatory and analgesic agents.
REFERENCES:
patent: 5162340 (1992-11-01), Chakravarty et al.
patent: 1122243 (2001-08-01), None
patent: 9500501 (1995-01-01), None
patent: 9636617 (1996-11-01), None
patent: 9738986 (1997-10-01), None
patent: 02083655 (2002-10-01), None
Tawada et al., 2003, CAS: 139:246034.
Chakravarty et al., 1994, CAS: 120:45975.
Almansa, Carmen, et al., “Synthesis and Structure-Activity Relationship of a New Series of COX-2 Selective Inhibitors: 1,5-Diarylimidazoles,” Journal of Medicinal Chemistry, 46(16): 3463-3475 (Jul. 31, 2003).
Almansa Rosales Carmen
Bartroli Orpi Javier
Palau Pharma, S.A.
Rothwell Figg Ernst & Manbeck
Shiao Rei-tsang
LandOfFree
Phosphoramide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphoramide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphoramide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4083244